Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Narcolepsy

U.S. Food and Drug Administration
Health / Medical / National

FDA Approves First Orexin-Targeting Narcolepsy Type 1 Drug

August 10, 2026August 8, 2026 - by Maryann Pugh

WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Takeda Pharmaceuticals America’s Orzeyful tablets for adults with narcolepsy type 1, making it the first treatment cleared to address the …

FDA Approves First Orexin-Targeting Narcolepsy Type 1 Drug Read More

Harmony Biosciences
Regional

Harmony Biosciences Presents Promising Preclinical Data for Novel Narcolepsy Treatment

June 16, 2025June 15, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences recently revealed compelling preclinical data for BP1.15205, a highly potent and selective orexin 2 receptor (OX2R) agonist, at the 39th Annual Meeting of the …

Harmony Biosciences Presents Promising Preclinical Data for Novel Narcolepsy Treatment Read More

Trending News

  • Woman Faces 10 Charges After Check Stolen From Mailbox

  • Gunpoint Robbery in Kennett Square Sparks Search for Suspect

  • Big Band Christmas Classics Come to West Chester’s Uptown

  • Overnight Theft Spree Hits Four North Coventry Neighborhood Streets

  • Holiday Stroll Brings Santa and Festive Fun to Yellow Springs

Subscribe for Updates

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Matylda Szydelko

Woman Faces 10 Charges After Check Stolen From Mailbox

November 17, 2026November 17, 2026

robbery suspect

Gunpoint Robbery in Kennett Square Sparks Search for Suspect

November 17, 2026November 16, 2026

Police News

Overnight Theft Spree Hits Four North Coventry Neighborhood Streets

November 16, 2026November 16, 2026

Copyright © 2026 MyChesCo.